Nilsine Partners
CVS icon

Nilsine Partners’s CVS Health CVS Stock Holding History

Nilsine Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.36M Buy
27,500
+23,256
+548% +$2.28M 0.16% 140
2026
Q2 		$439K Buy
4,244
+335
+9% +$29.9K 0.03% 317
2026
Q1 		$306K Sell
3,909
-201
-5% -$15.5K 0.02% 332
2025
Q4 		$326K Buy
4,110
+502
+14% +$39.6K 0.03% 321
2025
Q3 		$272K Buy
+3,608
New +$247K 0.02% 343
2024
Q4 		– Sell
-3,587
Closed -$226K – 367
2024
Q3 		$226K Sell
3,587
-1,365
-28% -$79.6K 0.03% 320
2024
Q2 		$292K Sell
4,952
-4,245
-46% -$266K 0.04% 280
2024
Q1 		$734K Buy
9,197
+770
+9% +$58.8K 0.1% 197
2023
Q4 		$665K Sell
8,427
-20
-0.2% -$1.42K 0.1% 201
2023
Q3 		$590K Buy
8,447
+154
+2% +$10.9K 0.09% 206
2023
Q2 		$573K Sell
8,293
-1,285
-13% -$91.4K 0.08% 216
2023
Q1 		$712K Buy
+9,578
New +$803K 0.11% 191

Other funds holding CVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Davis Selected Advisers
Davis Selected Advisers Tucson, Arizona $23.2B AUM 18.42% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Nilsine Partners's CVS Position: Q3 2026 in Review

Nilsine Partners increased its CVS Health (CVS) stake by 548% in Q3 2026, buying an estimated $2.28M and bringing the position to 27,500 shares worth $2.36M. The position accounts for 0.16% of the portfolio, ranked #140.

Nilsine Partners first reported a position in CVS in Q1 2023 and has held it in 12 quarters since. 1,324 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Nilsine Partners held 27,500 shares of CVS Health worth $2.36M as of Q3 2026.
  • Nilsine Partners bought 23,256 CVS Health shares in Q3 2026, an estimated $2.28M.
  • CVS Health made up 0.16% of Nilsine Partners's portfolio in Q3 2026, its #140 holding.
  • Nilsine Partners first reported a position in CVS Health in Q1 2023 and has held it in 12 quarters since.
  • 1,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Nilsine Partners's 13F filing for Q3 2026, filed 2 Nov 2026.